Mullen Yoko
From the Department of Translational Research and Cellular Therapeutics, Diabetes & Metabolism Research Institute, City of Hope, Duarte, CA.
Pancreas. 2017 Apr;46(4):455-466. doi: 10.1097/MPA.0000000000000828.
In 1974, the discovery of a mouse and a rat that spontaneously developed hyperglycemia led to the development of 2 autoimmune diabetes models: nonobese diabetic (NOD) mouse and Bio-Breeding rat. These models have contributed to our understanding of autoimmune diabetes, provided tools to dissect autoimmune islet damage, and facilitated development of early detection, prevention, and treatment of type 1 diabetes. The genetic characterization, monoclonal antibodies, and congenic strains have made NOD mice especially useful.Although the establishment of the inbred NOD mouse strain was documented by Makino et al (Jikken Dobutsu. 1980;29:1-13), this review will focus on the not-as-well-known history leading to the discovery of a glycosuric female mouse by Yoshihiro Tochino. This discovery was spearheaded by years of effort by Japanese scientists from different disciplines and dedicated animal care personnel and by the support of the Shionogi Pharmaceutical Company, Osaka, Japan. The history is based on the early literature, mostly written in Japanese, and personal communications especially with Dr Tochino, who was involved in diabetes animal model development and who contributed to the release of NOD mice to the international scientific community. This article also reviews the scientific contributions made by the Bio-Breeding rat to autoimmune diabetes.
1974年,一只自发出现高血糖的小鼠和一只大鼠的发现促成了两种自身免疫性糖尿病模型的建立:非肥胖糖尿病(NOD)小鼠和生物繁殖大鼠。这些模型有助于我们理解自身免疫性糖尿病,提供了剖析自身免疫性胰岛损伤的工具,并促进了1型糖尿病早期检测、预防和治疗方法的发展。基因特征、单克隆抗体和同源近交系使NOD小鼠尤为有用。尽管牧野等人记录了近交NOD小鼠品系的建立(《实验动物》,1980年;29:1 - 13),但本综述将聚焦于由户知野义博发现一只糖尿雌性小鼠的不太为人所知的历史。这一发现是由来自不同学科的日本科学家、敬业的动物饲养人员多年努力以及日本大阪盐野义制药公司的支持所推动的。这段历史基于早期文献,大多用日语撰写,以及特别是与户知野博士的个人交流,他参与了糖尿病动物模型的开发,并为将NOD小鼠引入国际科学界做出了贡献。本文还回顾了生物繁殖大鼠对自身免疫性糖尿病的科学贡献。